Scientists Say They ’ve Reached ‘Turning Point’ in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
“We’re getting something to work. Now we need to get it to work better,” said Dr. James Gulley, who help...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Deep-learning CT model helps predict ovarian cancer treatment response
A deep-learning model using CT images can predict neoadjuvant chemotherapy respons...Read more on AuntMinnie.comRelated Reading:
Radiomic features on CT help classify ovarian cancer subtypes
MRI has upper hand on CT for ovarian cancer detection
Body composition foretells ovarian cancer treatment complications
CT/ultrasound fusion enhances ovarian biopsies
Cinematic rendering enhances pelvic CT bone evaluation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2023 Category: Radiology Source Type: news
This simple surgery could slash ovarian cancer rates in Canada, specialists say
Uptake is on the rise for a procedure to remove the fallopian tubes, which can be the origin of ovarian cancer — a disease that is hard to detect or prevent. (Source: CBC | Health)
Source: CBC | Health - June 17, 2023 Category: Consumer Health News Tags: Radio/White Coat, Black Art Source Type: news
FDA Halts Enrollment in Mersana's Cancer Drug Studies FDA Halts Enrollment in Mersana's Cancer Drug Studies
Mersana Therapeutics said on Thursday the FDA had paused enrollment in two studies of its ovarian cancer drug after five deaths in bleeding-related events.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Promising Treatments for Pelvic Cancers
Which treatments for cervical and ovarian cancers are becoming the standard of care? (Source: WebMD Health)
Source: WebMD Health - June 9, 2023 Category: Consumer Health News Source Type: news
Simple Hysterectomy May Be Better Option for Cervical Cancer
Which treatments for cervical and ovarian cancers are becoming the standard of care? (Source: WebMD Health)
Source: WebMD Health - June 9, 2023 Category: Consumer Health News Source Type: news
Sequencing Strategy in Ovarian Cancer Helps Guide Treatment Sequencing Strategy in Ovarian Cancer Helps Guide Treatment
A targeted genetic sequencing strategy effectively identified homologous recombination DNA repair deficiency in ovarian cancer patients, and may eventually help predict treatment response.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 8, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Breakthrough as new test could detect deadly cancer in its early stages
It is hoped the new test could catch the most deadly form of ovarian cancer in its early stages. (Source: Daily Express - Health)
Source: Daily Express - Health - June 7, 2023 Category: Consumer Health News Source Type: news
Antibody-Drug Conjugate MIRV Improves OS in Ovarian Cancer Antibody-Drug Conjugate MIRV Improves OS in Ovarian Cancer
In the phase 3 MIRASOL study, the antibody-drug conjugate MIRV produced an overall survival benefit in women with platinum-resistant ovarian cancer.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Meta-Analysis Supports Ovarian Suppression in Breast Cancer Meta-Analysis Supports Ovarian Suppression in Breast Cancer
A new meta-analysis of 25 studies provides more evidence linking ovarian suppression/ablation in premenopausal women with breast cancer to less recurrence and longer survival.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 5, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Ovarian Cancer Drug Extends Survival in Resistant Disease
(MedPage Today) -- CHICAGO -- An antibody-microtubule inhibitor conjugate improved survival in selected patients with advanced platinum-resistant ovarian cancer compared with standard chemotherapy, representing the first novel drug to do so in... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 4, 2023 Category: Hematology Source Type: news
Hundreds of women could benefit from ovarian cancer drug pairing that doubles chance of remission
A new drug combination trialed by Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, was twice as effective as existing ovarian cancer treatments. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
Fresh drug combination promises to hold back the Ovarian cancer for FIVE YEARS
Around 7,500 women are diagnosed with ovarian cancer each year in the UK. As it causes few symptoms in early stages, it's picked up at a late stage in the majority of cases. (Source: the Mail online | Health)
Source: the Mail online | Health - June 3, 2023 Category: Consumer Health News Source Type: news
Pricey Drug Combo Boosts PFS in First-Line Advanced Ovarian Cancer
(MedPage Today) -- CHICAGO -- A three-drug combination significantly improved progression-free survival (PFS) in newly diagnosed non-BRCA advanced ovarian cancer but raised questions about the cost of the regimen, according to a study reported... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - June 3, 2023 Category: American Health Source Type: news
